Emerging role of sirtuins on tumorigenesis: Possible link between aging and cancer

BMB Reports

Volumn 46, Issue 9, 2013, Pages 429-438

  Cha, Yong I ^a   Kim, Hyun Seok ^b  

^a Norton Cancer Institute   (United States)

^b Ewha Womans University   (South Korea)

Author keywords

Acetylation; Aging; Deacetylase; Sirtuin; Tumorigenesis

Indexed keywords

SIRTUIN;

AGING; ANIMAL; APOPTOSIS; CARCINOGENESIS; CELL NUCLEUS; DNA REPAIR; GENOMIC INSTABILITY; HUMAN; METABOLISM; MITOCHONDRION; NEOPLASM; PATHOLOGY; SHORT SURVEY;

AGING; ANIMALS; APOPTOSIS; CARCINOGENESIS; CELL NUCLEUS; DNA REPAIR; GENOMIC INSTABILITY; HUMANS; MITOCHONDRIA; NEOPLASMS; SIRTUINS;

EID: 84885460070     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2013.46.9.180     Document Type: Short Survey

References (89)

1. Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. and Kroemer, G. (2013) The hallmarks of aging. Cell 153, 1194-1217.
2. Hanahan, D. and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674.
3. Hanahan, D. and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70.
4. Moskalev, A. A., Shaposhnikov, M. V., Plyusnina, E. N., Zhavoronkov, A., Budovsky, A., Yanai, H. and Fraifeld, V. E. (2012) The role of DNA damage and repair in aging ugh the prism of Koch-like criteria. Ageing Res. Rev. 12, 661-684.
5. Hoeijmakers, J. H. (2009) DNA damage, aging, and cancer. N. Engl. J. Med. 361, 1475-1485.
6. Blackburn, E. H., Greider, C. W. and Szostak, J. W. (2006) Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat. Med. 12, 1133-1138.
7. Fraga, M. F. and Esteller, M. (2007) Epigenetics and aging: the targets and the marks. Trends Genet. 23, 413-418.
8. Powers, E. T., Morimoto, R. I., Dillin, A., Kelly, J. W. and Balch, W. E. (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 78, 959-991.
9. Green, D. R., Galluzzi, L. and Kroemer, G. (2011) Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 333, 1109-1112.
10. Campisi, J. and d'Adda di Fagagna, F. (2007) Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729-740.
11. Rossi, D. J., Bryder, D., Seita, J., Nussenzweig, A., Hoeijmakers, J. and Weissman, I. L. (2007) Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447, 725-729.
12. Laplante, M. and Sabatini, D. M. (2012) mTOR signaling in growth control and disease. Cell. 149, 274-293.
13. Barzilai, N., Huffman, D. M., Muzumdar, R. H. and Bartke, A. (2012) The critical role of metabolic pathways in aging. Diabetes 61, 1315-1322.
14. Imai, S., Armstrong, C. M., Kaeberlein, M. and Guarente, L. (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800.
15. Frye, R. A. (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273, 793-798.
16. Baur, J. A., Ungvari, Z., Minor, R. K., Le Couteur, D. G. and de Cabo, R. (2012) Are sirtuins viable targets for im proving healthspan and lifespan? Nat. Rev. Drug Discov. 11, 443-461.
17. Haigis, M. C. and Sinclair, D. A. (2010) Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5, 253-295.
18. Lee, S. H. and Min, K. J. (2013) Caloric restriction and its mimetics. BMB Rep. 46, 181-187.
19. Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., He, B., Chen, W., Zhang, S., Cerione, R. A., Auwerx, J., Hao, Q. and Lin, H. (2011) Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806-809.
20. Jiang, H., Khan, S., Wang, Y., Charron, G., He, B., Sebastian, C., Du, J., Kim, R., Ge, E., Mostoslavsky, R., Hang, H. C., Hao, Q. and Lin, H. (2013) SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine. Nature 496, 110-113.
21. Roth, M. and Chen, W. Y. (2013) Sorting out functions of sirtuins in cancer. Oncogene. Apr 22. doi: 10.1038/onc. 2013.120. [Epub ahead of print].
22. Morris, B. J. (2013) Seven sirtuins for seven deadly diseases of aging. Free Radic. Biol. Med. 56, 133-171.
23. Martinez-Pastor, B. and Mostoslavsky, R. (2012) Sirtuins, metabolism, and cancer. Front Pharmacol. 2012;3:22. doi: 10.3389/fphar.2012.00022. Epub 2012 Feb 21.
24. Hall, J. A., Dominy, J. E., Lee, Y. and Puigserver, P. (2013) The sirtuin family's role in aging and age-associated pathologies. J. Clin Invest. 123, 973-979.
25. Dryden, S. C., Nahhas, F. A., Nowak, J. E., Goustin, A. S. and Tainsky, M. A. (2003) Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell Biol. 23, 3173-3185.
26. Serrano, L., Martínez-Redondo, P., Marazuela-Duque, A., Vazquez, B. N., Dooley, S. J., Voigt, P., Beck, D. B., Kane-Goldsmith, N., Tong, Q., Rabanal, R. M., Fondevila, D., Muñoz, P., Krüger, M., Tischfield, J. A. and Vaquero, A. (2013) The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation. Genes Dev. 27, 639-653.
27. Wilson, J. M., Le, V. Q., Zimmerman, C., Marmorstein, R. and Pillus, L. (2006) Nuclear export modulates the cytoplasmic Sir2 homologue Hst2. EMBO Rep. 7, 1247-1251.
28. North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M. and Verdin, E. (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol. Cell. 11, 437-444.
29. Jing, E., Gesta, S. and Kahn, C. R. (2007) SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab. 6, 105-114.
30. Wang, F., Nguyen, M., Qin, F. X. and Tong, Q. (2007) SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell. 6, 505-514.
31. Jin, Y. H., Kim, Y. J., Kim, D. W., Baek, K. H., Kang, B. Y., Yeo, C. Y. and Lee, K. Y. (2008) Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53. Biochem. Biophys. Res. Commun. 368, 690-695.
32. Kim, H. S., Vassilopoulos, A., Wang, R. H., Lahusen, T., Xiao, Z., Xu, X., Li, C., Veenstra, T. D., Li, B., Yu, H., Ji, J., Wang, X. W., Park, S. H., Cha, Y. I., Gius, D. and Deng, C. X. (2011) SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell. 20, 487-499.
33. Jiang, W., Wang, S., Xiao, M., Lin, Y., Zhou, L., Lei, Q., Xiong, Y., Guan, K. L. and Zhao, S. (2011) Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol. Cell. 43, 33-44.
34. Das, C., Lucia, M. S., Hansen, K. C. and Tyler, J. K. (2009) CBP/p300-mediated acetylation of histone H3 on lysine Nature 459, 113-117.
35. North, B. J. and Verdin, E. (2007) Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation. J. Biol. Chem. 282, 19546-19555.
36. Pandithage, R., Lilischkis, R., Harting, K., Wolf, A., Jedamzik, B., Lüscher-Firzlaff, J., Vervoorts, J., Lasonder, E., Kremmer, E., Knöll, B. and Lüscher, B. (2008) The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility. J. Cell Biol. 180, 915-929.
37. Donmez, G. and Outeiro, T. F. (2013) SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol. Med. 5, 344-352.
38. Outeiro, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., Strathearn, K. E., Amore, A. M., Volk, C. B., Maxwell, M. M., Rochet, J. C., McLean, P. J., Young, A. B., Abagyan, R., Feany, M. B., Hyman, B. T. and Kazantsev, A. G. (2007) Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 317, 516-519.
39. Narayan, N., Lee, I. H., Borenstein, R., Sun, J., Wong, R., Tong, G., Fergusson, M. M., Liu, J., Rovira, I. I., Cheng, H. L., Wang, G., Gucek, M., Lombard, D., Alt, F., Sack, M. N., Murphy, E., Cao, L. and Finkel, T. (2013) The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature 492, 199-204.
40. Hiratsuka, M., Inoue, T., Toda, T., Kimura, N., Shirayoshi, Y., Kamitani, H., Watanabe, T., Ohama, E., Tahimic, C. G., Kurimasa, A. and Oshimura, M. (2003) Proteomicsbased identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. BBRC 309, 558-566.
41. Inoue, T., Hiratsuka, M., Osaki, M., Yamada, H., Kishimoto, I., Yamaguchi, S., Nakano, S., Katoh, M., Ito, H. and Oshimura, M. (2007) SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress. Oncogene. 26, 945-957.
42. Inoue, T., Hiratsuka, M., Osaki, M. and Oshimura, M. (2007) The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle 6, 1011-1018.
43. Lai, C. C., Lin, P. M., Lin, S. F., Hsu, C. H., Lin, H. C., Hu, M. L., Hsu, C. M. and Yang, M. Y. (2013) Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol. 34, 1847-1854.
44. Ong, C. A., Shapiro, J., Nason, K. S., Davison, J. M., Liu, X., Ross-Innes, C., O'Donovan, M., Dinjens, W. N., Biermann, K., Shannon, N., Worster, S., Schulz, L. K., Luketich, J. D., Wijnhoven, B. P., Hardwick, R. H. and Fitzgerald, R. C. (2013) Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prog nosis for patients with esophageal adenocarcinoma. J. Clin. Oncol. 31, 1576-1582.
45. Dan, L., Klimenkova, O., Klimiankou, M., Klusman, J. H., van den Heuvel-Eibrink, M. M., Reinhardt, D., Welte, K. and Skokowa, J. (2012) The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells. Haematologica. 97, 551-559.
46. Liu, P. Y., Xu, N., Malyukova, A., Scarlett, C. J., Sun, Y. T., Zhang, X. D., Ling, D., Su, S. P., Nelson, C., Chang, D. K., Koach, J., Tee, A. E., Haber, M., Norris, M. D., Toon, C., Rooman, I., Xue, C., Cheung, B. B., Kumar, S., Marshall, G. M., Biankin, A. V. and Liu, T. (2013) The histone deacetylase SIRT2 stabilizes Myc oncoproteins. Cell Death Differ. 20, 503-514.
47. Chen, J., Chan, A. W., To, K. F., Chen, W., Zhang, Z., Ren, J., Song, C., Cheung, Y. S., Lai, P. B., Cheng, S. H., Ng, M. H., Huang, A. and Ko, B. C. (2013) SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3β/β-catenin signaling. Hepatology 57, 2287-2298.
48. Yang, M. H., Laurent, G., Bause, A. S., Spang, R., German, N., Haigis, M. C. and Haigis, K. M. (2013) HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS. Mol. Cancer Res. [Epub ahead of print].
49. Huang, J. Y., Hirschey, M. D., Shimazu, T., Ho, L. and Verdin, E. (2010) Mitochondrial sirtuins. Biochim. Biophys. Acta. 1804, 1645-1651.
50. Kim, S. C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, H., Xiao, L., Grishin, N. V., White, M., Yang, X. J. and Zhao, Y. (2006) Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell. 23, 607-618.
51. Ahn, B. H., Kim, H. S., Song, S., Lee, I. H., Liu, J., Vassilopoulos, A., Deng, C. X. and Finkel, T. (2008) A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 105, 14447-14452.
52. Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., Grueter, C. A., Harris, C., Biddinger, S., Ilkayeva, O. R., Stevens, R. D., Li, Y., Saha, A. K., Ruderman, N. B., Bain, J. R., Newgard, C. B., Farese, R. V. Jr., Alt, F. W., Kahn, C. R. and Verdin, E. (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121-125.
53. Kong, X., Wang, R., Xue, Y., Liu, X., Zhang, H., Chen, Y., Fang, F. and Chang, Y. (2010) Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 5, e11707.
54. Kim, H. S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., van der Meer, R., Nguyen, P., Savage, J., Owens, K. M., Vassilopoulos, A., Ozden, O., Park, S. H., Singh, K. K., Abdulkadir, S. A., Spitz, D. R., Deng, C. X. and Gius, D. (2010) SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 17, 41-52.
55. Anderson, K. A. and Hirschey, M. D. (2012) Mitochondrial protein acetylation regulates metabolism. Essays Biochem. 52, 23-35.
56. Someya, S., Yu, W., Hallows, W. C., Xu, J., Vann, J. M., Leeuwenburgh, C., Tanokura, M., Denu, J. M. and Prolla, T. A. (2010) Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143, 802-812.
57. Hebert, A. S., Dittenhafer-Reed, K. E., Yu, W., Bailey, D. J., Selen, E. S., Boersma, M. D., Carson, J. J., Tonelli, M., Balloon, A. J., Higbee, A. J., Westphall, M. S., Pagliarini, D. J., Prolla, T. A., Assadi-Porter, F., Roy, S., Denu, J. M. and Coon, J. J. (2013) Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell 49, 186-199.
58. Tao, R., Coleman, M. C., Pennington, J. D., Ozden, O., Park, S. H., Jiang, H., Kim, H. S., Flynn, C. R., Hill, S., Hayes McDonald, W., Olivier, A. K., Spitz, D. R. and Gius, D. (2010) Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol. Cell 40, 893-904.
59. Chen, Y., Zhang, J., Lin, Y., Lei, Q., Guan, K. L., Zhao, S. and Xiong, Y. (2011) Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep. 12, 534-541.
60. Finley, L. W., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P. I., Cardoso, S. M., Clish, C. B., Pandolfi, P. P. and Haigis, M. C. (2011) SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell 19, 416-428.
61. Inuzuka, H., Gao, D., Finley, L. W., Yang, W., Wan, L., Fukushima, H., Chin, Y. R., Zhai, B., Shaik, S., Lau, A. W., Wang, Z., Gygi, S. P., Nakayama, K., Teruya-Feldstein, J., Toker, A., Haigis, M. C., Pandolfi, P. P. and Wei, W. (2012) Acetylation-dependent regulation of Skp2 function. Cell 50, 179-193.
62. Finley, L. W. and Haigis, M. C. (2012) Metabolic regulation by SIRT3: implications for tumorigenesis. Trends Mol. Med. 18, 516-523.
63. Haigis, M. C., Mostoslavsky, R., Haigis, K. M., Fahie, K., Christodoulou, D. C., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., Karow, M., Blander, G., Wolberger, C., Prolla, T. A., Weindruch, R., Alt, F. W. and Guarente, L. (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126, 941-954.
64. Laurent, G., German, N. J., Saha, A. K., de Boer, V. C., Davies, M., Koves, T. R., Dephoure, N., Fischer, F., Boanca, G., Vaitheesvaran, B., Lovitch, S. B., Sharpe, A. H., Kurland, I. J., Steegborn, C., Gygi, S. P., Muoio, D. M., Ruderman, N. B. and Haigis, M. C. (2013) SIRT4 Coordinates the Balance between Lipid Synthesis and Catabolism by Repressing Malonyl CoA Decarboxylase. Mol. Cell 50, 686-698.
65. Nasrin, N., Wu, X., Fortier, E., Feng, Y., Bare', O. C., Chen, S., Ren, X., Wu, Z., Streeper, R. S. and Bordone, L. (2010) SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J. Biol. Chem. 285, 31995-32002.
66. Yang, H., Yang, T., Baur, J. A., Perez, E., Matsui, T., Carmona, J. J., Lamming, D. W., Souza-Pinto, N. C., Bohr, V. A., Rosenzweig, A., de Cabo, R., Sauve, A. A. and Sinclair, D. A. (2007) Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130, 1095-1107.
67. Jeong, S. M., Xiao, C., Finley, L. W., Lahusen, T., Souza, A. L., Pierce, K., Li, Y. H., Wang, X., Laurent, G., German, N. J., Xu, X., Li, C., Wang, R. H., Lee, J., Csibi, A., Cerione, R., Blenis, J., Clish, C. B., Kimmelman, A., Deng, C. X. and Haigis, M. C. (2013) SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23, 450-463.
68. Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., He, B., Chen, W., Zhang, S., Cerione, R. A., Auwerx, J., Hao, Q. and Lin, H. (2011) Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806-809.
69. Nakagawa, T., Lomb, D. J., Haigis, M. C. and Guarente, L. (2009) SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560-570.
70. Park, J., Chen, Y., Tishkoff, D. X., Peng, C., Tan, M., Dai, L., Xie, Z., Zhang, Y., Zwaans, B. M., Skinner, M. E., Lombard, D. B. and Zhao, Y. (2013) SIRT5-Mediated Lysine Desuccinylation Impacts Diverse Metabolic Pathways. Mol. Cell 50, 919-930.
71. Jia, G., Su, L., Singhal, S. and Liu, X. (2012) Emerging roles of SIRT6 on telomere maintenance, DNA repair, metabolism and mammalian aging. Mol. Cell Biochem. 364, 345-350.
72. Jiang, H., Khan, S., Wang, Y., Charron, G., He, B., Sebastian, C., Du, J., Kim, R., Ge, E., Mostoslavsky, R., Hang, H. C., Hao, Q. and Lin, H. (2013) SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine. Nature 496, 110-113.
73. Mostoslavsky, R., Chua, K. F., Lombard, D. B., Pang, W. W., Fischer, M. R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M. M., Mills, K. D., Patel, P., Hsu, J. T., Hong, A. L., Ford, E., Cheng, H. L., Kennedy, C., Nunez, N., Bronson, R., Frendewey, D., Auerbach, W., Valenzuela, D., Karow, M., Hottiger, M. O., Hursting, S., Barrett, J. C., Guarente, L., Mulligan, R., Demple, B., Yancopoulos, G. D. and Alt, F. W. (2006) Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315-329.
74. Michishita, E., McCord, R. A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T. L., Barrett, J. C., Chang, H. Y., Bohr, V. A., Ried, T., Gozani, O. and Chua, K. F. (2008) SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452, 492-496.
75. Yang, B., Zwaans, B. M., Eckersdorff, M. and Lombard, D. B. (2009) The sirtuin SIRT6 deacetylates H3K56Ac in vivo to promote genomic stability. Cell Cycle. 8, 2662-2663.
76. Kaidi, A., Weinert, B. T., Choudhary, C. and Jackson, S. P. (2010) Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 329, 1348-1353.
77. Mao, Z., Hine, C., Tian, X., Van Meter, M., Au, M., Vaidya, A., Seluanov, A. and Gorbunova, V. (2011) SIRT6 promotes DNA repair under stress by activating PARP1. Science 332, 1443-1446.
78. Zhong, L., D'Urso, A., Toiber, D., Sebastian, C., Henry, R. E., Vadysirisack, D. D., Guimaraes, A., Marinelli, B., Wikstrom, J. D., Nir, T., Clish, C. B., Vaitheesvaran, B., Iliopoulos, O., Kurland, I., Dor, Y., Weissleder, R., Shirihai, O. S., Ellisen, L. W., Espinosa, J. M. and Mostoslavsky, R. (2010) The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 140, 280-293
79. Sebastián, C., Zwaans, B. M., Silberman, D. M., Gymrek, M., Goren, A., Zhong, L., Ram, O., Truelove, J., Guimaraes, A. R., Toiber, D., Cosentino, C., Greenson, J. K., MacDonald, A. I., McGlynn, L., Maxwell, F., Edwards, J., Giacosa, S., Guccione, E., Weissleder, R., Bernstein, B. E., Regev, A., Shiels, P. G., Lombard, D. B. and Mostoslavsky, R. (2012) The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151, 1185-1199.
80. Min, L., Ji, Y., Bakiri, L., Qiu, Z., Cen, J., Chen, X., Chen, L., Scheuch, H., Zheng, H., Qin, L., Zatloukal, K., Hui, L. and Wagner, E. F. (2012) Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat. Cell Biol. 14, 1203-1211.
81. Xiao, C., Wang, R. H., Lahusen, T. J., Park, O., Bertola, A., Maruyama, T., Reynolds, D., Chen, Q., Xu, X., Young, H. A., Chen, W. J., Gao, B. and Deng, C. X. (2012) Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice. J. Biol. Chem. 287, 41903-41913.
82. Marquardt, J. U., Fischer, K., Baus, K., Kashyap, A., Ma, S., Krupp, M., Linke, M., Teufel, A., Zechner, U., Strand, D., Thorgeirsson, S. S., Galle, P. R. and Strand, S. (2013) SIRT6 dependent genetic and epigenetic alterations are associated with poor clinical outcome in HCC patients. Hepatology doi: 10.1002/hep.26413. [Epub ahead of print].
83. Bauer, I., Grozio, A., Lasigliè, D., Basile, G., Sturla, L., Magnone, M., Sociali, G., Soncini, D., Caffa, I., Poggi, A., Zoppoli, G., Cea, M., Feldmann, G., Mostoslavsky, R., Ballestrero, A., Patrone, F., Bruzzone, S. and Nencioni, A. (2012) The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. J. Biol. Chem. 287, 40924-40937.
84. Khongkow, M., Olmos, Y., Gong, C., Gomes, A. R., Monteiro, L. J., Yagüe, E., Cavaco, T. B., Khongkow, P., Man, E. P., Laohasinnarong, S., Koo, C. Y., Harada-Shoji, N., Tsang, J. W., Coombes, R. C., Schwer, B., Khoo, U. S. and Lam, E. W. (2013) SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer. Carcinogenesis. 34, 1476-1486.
85. Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I. and Guarente, L. (2006) Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20, 1075-1080.
86. Vakhrusheva, O., Smolka, C., Gajawada, P., Kostin, S., Boettger, T., Kubin, T., Braun, T. and Bober, E. (2008) Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 102, 703-710.
87. Barber, M. F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., Moqtaderi, Z., Tennen, RI., Paredes, S., Young, N. L., Chen, K., Struhl, K., Garcia, B. A., Gozani, O., Li, W. and Chua, K. F. (2012) SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487, 114-118.
88. Yoon, I. S., Chung, J. H., Hahm, S. H., Park, M. J., Lee, Y. R., Kang, L. W., Kim, T. S., Kim, J. and Han, Y. S. (2011) Ribosomal protein S3 is phosphorylated by Cdk1/cdc2 during G2/M phase. BMB Rep. 44, 529-534.
89. Kim, J. K., Noh, J. H., Jung, K. H., Eun, J. W., Bae, H. J., Kim, M. G., Chang, Y. G., Shen, Q., Park, W. S., Lee, J. Y., Borlak, J. and Nam, S. W. (2013) Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology 57, 1055-1067.